Health Care
Manufacturers: Price Controls Harm Innovation, Therapies and Cures; Congress Should Look at PBMs to Cut Drug Costs
Washington, D.C. – Following the release of prices set for the first 10 prescription drugs that were subject to price controls under the Inflation Reduction Act, National Association of Manufacturers President and CEO Jay Timmons released the following statement: “The pricing mandates released by the Department of Health and Human Services on groundbreaking medicines harm …
Manufacturers Commend House Ways and Means Committee’s Efforts Toward Comprehensive PBM Reform
Bill Would Protect Seniors and Set the Stage for Broader Reforms
Washington, D.C. – Following the House Ways and Means Committee’s unanimous approval of legislation to reform pharmacy benefit managers—middlemen who unfairly increase the prices that patients pay at the pharmacy counter by controlling negotiations between insurers and biopharmaceutical manufacturers—in Medicare markets, National Association of Manufacturers President and CEO Jay Timmons released the following statement: “The …
